As a Contract Research Organization (CRO), Franklin Biolabs is redefining the landscape of the global cell and gene therapy industry by providing a full range of services from discovery to commercial approval. With decades of expertise and a steadfast commitment to excellence, we bridge the gap between groundbreaking research and the delivery of transformative advanced therapies to patients.
Franklin Biolabs leverages our broad range of capabilities & expertise with a focus on vector production, analytical testing, preclinical, pharmacology and toxicology studies, pathology, immunology, and bioanalytical services to accelerate discovery through clinical trials.
Please visit the respective pages to view our specific services:
